Combination product
This product contains more than one active ingredient, so it has no single molecular structure.
Registration
- Applicants
- 1
- Registrations
- 1
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Aspen SA Operations (Pty) Ltd | Pneumo aspen | Not stated | 570918 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Pneumo aspen EACH 0,5 ml DOSE CONTAINS: SACCHARIDE FOR SEROTYPE 1 2,0 μg SACCHARIDE FOR SEROTYPE 5 2,0 μg SACCHARIDE FOR SEROTYPE 6A 2,0 μg SACCHARIDE FOR SEROTYPE 6B 4,0 μg SACCHARIDE FOR SEROTYPE 7F 2,0 μg SACCHARIDE FOR SEROTYPE 9V 2,0 μg SACCHARIDE FOR SEROTYPE 14 2,0 μg SACCHARIDE FOR SEROTYPE 19A 2,0 μg SACCHARIDE FOR SEROTYPE 19F 2,0 μg SACCHARIDE FOR SEROTYPE 23F 2,0 μg SEROTYPES ARE CONJUGATED TO CRM197 CARRIER PROTEIN 19 to 48 μg | Not listed | 57091857/30.2/0918 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Background
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.